CAM
ATRC icon

Crestone Asset Management’s AtriCure ATRC Stock Holding History

Crestone Asset Management’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-11,000
Closed -$226K – 44
2018
Q1 		$226K Buy
+11,000
New +$199K 0.1% 42

Other funds holding ATRC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
HEC
Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Crestone Asset Management's ATRC Position: Q2 2018 in Review

Crestone Asset Management sold out of AtriCure (ATRC) in Q2 2018, closing a stake of 11,000 shares — an estimated $226K sold.

Crestone Asset Management first reported a position in ATRC in Q1 2018 and held it in 1 quarter. The position peaked at $226K in Q1 2018. 108 funds tracked by Wall St. Rank hold ATRC as of Q2 2018.

  • Crestone Asset Management reported no remaining AtriCure position as of Q2 2018 after selling out during the quarter.
  • Crestone Asset Management sold 11,000 AtriCure shares in Q2 2018, an estimated $226K.
  • Crestone Asset Management first reported a position in AtriCure in Q1 2018 and held it in 1 quarter.
  • Crestone Asset Management's AtriCure position peaked at $226K in Q1 2018.
  • 108 funds tracked by Wall St. Rank held AtriCure as of Q2 2018.

Based on Crestone Asset Management's 13F filing for Q2 2018, filed 12 Mar 2021.